While compounded versions are a cheap and sometimes effective alternative to these pricey drugs, they still come with many risks
Stomach side effects can be more common with higher doses
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage gastrointestinal risks
According to the Food and Drug Administration (FDA), When a manufacturer applies for FDA approval of a drug, regulations require them to provide stability testing with a recommended expiration date and storage conditions
it cannot be legally prescribed or supplied as a standard treatment in the UK
If you are coming from another GLP-1 agonist, reading the semaglutide to tirzepatide conversion chart or the switching dosage chart can help you decide where in the retatrutide titration to begin